JPMA Draft Guidelines Urge Companies to Separate Ad Reviewing Bodies from Sales Units

Drug makers belonging to the Japan Pharmaceutical Manufacturers Association (JPMA) will be required under the association’s new guidelines to set up in-house advertising review divisions that are independent from their sales divisions. The JPMA presented at a closed-door meeting on...read more